A. Richard Newton Distinguished Innovator Lecture Series – Dr. Jennifer Doudna, April 23, 2019, UC, Berkeley | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« One or More Clinical Trials to get FDA Approve a Drug?

Alter the Code of Life – Technologies for Gene Editing from MammothBiosciences, San Francisco, CA »

A. Richard Newton Distinguished Innovator Lecture Series – Dr. Jennifer Doudna, April 23, 2019, UC, Berkeley

May 16, 2019 by 2012pharmaceutical

A. Richard Newton Distinguished Innovator Lecture Series – Dr. Jennifer Doudna, April 23, 2019, UC, Berkeley

2.1.5.1

2.1.5.1 A. Richard Newton Distinguished Innovator Lecture Series – Dr. Jennifer Doudna, April 23, 2019, UC, Berkeley, Volume 2 (Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology), Part 2: CRISPR for Gene Editing and DNA Repair

FEATURED SPEAKERS

Last month, Dr. Jennifer Doudna spoke with the Sutardja Center at the A. Richard Newton Distinguished Innovator Lecture Series. Dr. Doudna is a UC Berkeley Professor, co-inventor of CRISPR and co-author of A Crack in Creation and cofounder of Mammoth Biosciences; Caribou Biosciences; Intellia Therapeutics and Editas Medicine. Whether or not your passion is bio-tech, this lecture will be relevant to all of us, since the innovations in gene editing technology will change our lives.

Dr. Doudna recently wrote in an article for Time’s most influential people… “Since 2012, when CRISPR-Cas9 transformed research, scientists have purposely taken a cautious and deliberate approach, focusing on how to safely apply genome editing to cure genetic diseases, fight cancer, accelerate drug development, create transplant organs and develop more nutritious crops. Its potential to improve our lives is enormous. But its potential to harm, with unintended side effects, is still unknown.”

Click here or the picture above to w atch the full video!